Maternal Methyl-Nutrient Status and Infant Neurodevelopment Study

Sponsor
Far Eastern Memorial Hospital
Study ID
NCT07568561
Status
Recruiting
Apply to this trial

Conditions

  • Birth Outcomes
  • Dietary Intake Assessment
  • Dietary Quality
  • Homocysteine
  • Infant Neurodevelopment
  • Methylation
  • Nutrition
  • Pregnancy
  • Trimethylamine N-oxide (TMAO)

Eligibility Criteria

Sex
ALL
Age
0 Days - 45 Years
Healthy Volunteers
Accepted

Study Details

This prospective cohort study examines the relationship between maternal methyl-nutrient status during pregnancy and offspring neurodevelopment. It integrates maternal dietary, biomarker, genetic, and microbiome data and follows children up to 24 months.

Key Dates

First listed
May 6, 2026
Start date
May 27, 2026
Status verified
Jan 2026
Primary completion
Jan 18, 2029
Completion
Jan 18, 2029

Study Design

Enrollment
240 participants (estimated)

Arms

  • Arm: FEMHPregnancy cohort
    Throughout pregnancy, delivery, and infant follow-up at FEMH

Primary Outcome Measure

Ｍaternal methyl-nutrient and other nutrition status [ Time Frame: From enrollment to delivery (approximately 9 months) ]

Central Contacts

Related Studies